Esthesioneuroblastoma.
A retrospective review of the clinical records of 31 patients with esthesioneuroblastoma is presented. A bimodal age distribution was noted. The tumor is extremely rare among blacks. Most patients presented with locally advanced disease. However, regional and distant metastases at the time of initial diagnosis are uncommon. Local recurrence at the primary site was very common, and this reflects either the conservative initial surgical treatment employed or the multicentric nature of the tumor. Cervical lymph node metastasis is present in less than 10 percent of patients at the time of diagnosis. Survival rates were better in patients with early stages of disease. From this study we conclude that the current management of these tumors should consist of a combination of radiation and surgery. Radical resection followed by postoperative radiotherapy appears to be the treatment combination of choice. The 5 year survival rate in our series was 52 percent.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D006801:Humans; D008875:Middle Aged; D018241:Neuroectodermal Tumors, Primitive, Peripheral / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D009669:Nose Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D009831:Olfactory Mucosa; D012189:Retrospective Studies